Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional

7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

ClinicalTrials.gov ID: NCT05480761

Public ClinicalTrials.gov record NCT05480761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of a 7-Day Therapeutic Trial Dose of Commercial Sucraid® (Sacrosidase) Oral Solution for Alleviating Congenital Sucrase-Isomaltase Deficiency (CSID) Symptoms in Pediatric Subjects With Low, Moderate, and Normal Sucrase Levels

Study identification

NCT ID
NCT05480761
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
QOL Medical, LLC
Industry
Enrollment
312 participants

Conditions and interventions

Interventions

  • Sucraid (sacrosidase) Oral Solution 8500 IU/mL Biological

Biological

Eligibility (public fields only)

Age range
6 Months to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2022
Primary completion
Sep 17, 2024
Completion
Sep 17, 2024
Last update posted
Mar 19, 2025

2022 – 2024

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
16
Facility City State ZIP Site status
Children's Hospital Los Angeles Los Angeles California 90027
UCSF Benioff Children's Hospital Oakland Oakland California 94609
Kidz Medical Coral Gables Florida 33146
Orlando Health Orlando Florida 32806
Children's Healthcare of Atlanta Atlanta Georgia 30329
Center for Digestive Health Care, LLC Atlanta Georgia 30342
University of Maryland Baltimore Baltimore Maryland 21201
Johns Hopkins University Baltimore Maryland 21205
GI Associates Flowood Mississippi 39232
Happy Tummies Flowood Mississippi 39232
Children's Mercy Hospital Kansas City Missouri 64108
Atlantic Health System Morristown New Jersey 07960
WNY Pediatric Gastroenterology Buffalo New York 14225
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Measurable Outcomes Research Oklahoma City Oklahoma 73112
Prisma Health Greenville South Carolina 29615
GI For Kids, PLLC Knoxville Tennessee 32963
Newco 3A Research,LLC DBA 3A Research El Paso Texas 79902
Pediatric GI of El Paso, LLC El Paso Texas 79925
McGovern Medical School of UT Health Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05480761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 19, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05480761 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →